Pain evaluation
allo-WJ-MSC-treated diabetic, Pain, pain
We measured the pain intensity at rest by Visual Analogue Scale (VAS) at the beginning of the study and after 1, 3, 6, and 12 months of follow-up. The pain evaluation measures showed statistically significant differences between the auto-BM-MNC or allo-WJ-MSC approaches compared to the placebo group at all the times of follow-up (Fig. Pain intensity at rest decreased dramatically in the auto-BM-MNC and allo-WJ-MSC-treated diabetic patients with CTLI. Pain decreased in participants treated with auto-BM-MNC or allo-WJ-MSC approaches from the first month compared to the placebo group. Measurements are expressed as mean ± standard deviation. Significant differences between: placebo group versus auto-BM-MNC group (#) (